/
LLBO
$0.00+$0.00 (+75.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
54% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.0K | $60.0K | $350.0K | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $2.5K | $2.5K | $630 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $62.5K | $57.5K | $349.4K | $0 | $0 | $0 | $0 | $0 |
| Gross margin | 96.1% | 95.8% | 99.8% | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $2.6K | $5.9K | $241.9K | −$43.4K | −$6.3K | −$4.4K | −$5.8K | −$58.3K |
| EBITDA | $5.1K | $8.5K | $242.5K | −$43.4K | −$6.3K | −$2.7K | −$5.8K | −$58.3K |
| Net income | $2.6K | $5.9K | $241.9K | −$43.4K | −$6.3K | −$2.7K | −$5.8K | −$58.3K |
| Net margin | 4.0% | 9.9% | 69.1% | — | — | — | — | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
LIFELINE BIOTECHS INC NEW
LIFELINE BIOTECHS INC NEW
Held by traders on TradeandTell
No one on the platform currently holds LLBO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in LLBO as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded LLBO yet.
